71 related articles for article (PubMed ID: 9351465)
41. [Value of angiotensin II-antagonists].
Internist (Berl); 1998 Sep; 39(9 Suppl Zum Stelle):1-4. PubMed ID: 9772714
[No Abstract] [Full Text] [Related]
42. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
Costantino S; Millozzi F; Scarlata S
Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
[No Abstract] [Full Text] [Related]
43. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
[TBL] [Abstract][Full Text] [Related]
44. [New therapeutic principle in the management of cardiac insufficiency: A II antagonists. Results of the ELITE study (Evaluation of Losartan In The Elderly)].
Dtsch Med Wochenschr; 1997 Sep; 122(39 Suppl):1-4. PubMed ID: 9351465
[No Abstract] [Full Text] [Related]
45. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
Hunyady L; Nagy L
Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
[TBL] [Abstract][Full Text] [Related]
46. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
McMurray JJ
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
[No Abstract] [Full Text] [Related]
47. [Losartan--a nonpeptide antagonist of angiotensin-II receptors in the treatment of heart failure].
Berezin AE; Fushteĭ IM
Klin Med (Mosk); 1998; 76(7):12-5. PubMed ID: 9742770
[No Abstract] [Full Text] [Related]
48. [The outlook for the use of the nonpeptide angiotensin II-receptor antagonist losartan in treating heart failure].
Dunaev VV; Berezin AE
Eksp Klin Farmakol; 1999; 62(4):77-80. PubMed ID: 10513345
[No Abstract] [Full Text] [Related]
49. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
50. [Current therapy: losartan].
Degaute JP; Sternon J
Rev Med Brux; 1997 Oct; 18(5):335-8. PubMed ID: 9441330
[TBL] [Abstract][Full Text] [Related]
51. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
Karlsen FM; Kamper AL
Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
